---
figid: PMC6356788__cancers-11-00090-g002
figlink: /pmc/articles/PMC6356788/figure/cancers-11-00090-f002/
number: F2
caption: FoxO functions in cell response to antitumor drugs. The main cellular pathways
  regulated by FoxOs and involved in drug response and resistance of conventional
  and target-specific antitumor drugs are reported. The drug and the corresponding
  cellular response pathway are shown in different colors.
pmcid: PMC6356788
papertitle: Role of FoxO Proteins in Cellular Response to Antitumor Agents.
reftext: Giovanni Luca Beretta, et al. Cancers (Basel). 2019 Jan;11(1):90.
pmc_ranked_result_index: '5152'
pathway_score: 0.9517297
filename: cancers-11-00090-g002.jpg
figtitle: FoxO functions in cell response to antitumor drugs
year: '2019'
organisms: Homo sapiens
ndex: dea68b61-dea8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6356788__cancers-11-00090-g002.html
  '@type': Dataset
  description: FoxO functions in cell response to antitumor drugs. The main cellular
    pathways regulated by FoxOs and involved in drug response and resistance of conventional
    and target-specific antitumor drugs are reported. The drug and the corresponding
    cellular response pathway are shown in different colors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MYC
  - MAPK3
  - MAPK1
  - EGFR
  - MAP3K5
  - BCL2L11
  - CDC25B
  - AKT1
  - FOXO6
  - FOXO1
  - AKT3
  - SLTM
  - AKT2
  - BIRC5
  - TGFB1
  - CXCL8
  - FOXO3
  - FOXO4
  - ERBB2
  - Lapatinib
  - Gefitinib
  - Paclitaxel
  - Met
  - Cisplatin
  - Doxorubicin
  - Cancer
genes:
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ASK1
  symbol: ASK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K5
  entrez: '4217'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: CDC25B
  symbol: CDC25B
  source: hgnc_symbol
  hgnc_symbol: CDC25B
  entrez: '994'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FoxOs
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: FoxOs
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: TGF-B1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: FoxOs
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FoxOs
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: Her2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
chemicals:
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Gefitinib
  source: MESH
  identifier: C419708
- word: Paclitaxel
  source: MESH
  identifier: D017239
- word: Met
  source: MESH
  identifier: C034758
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Doxorubicin
  source: MESH
  identifier: D004317
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6356788__F2
redirect_from: /figures/PMC6356788__F2
figtype: Figure
---
